PDGFRB
MOLECULAR TARGETplatelet derived growth factor receptor beta
PDGFRB (platelet derived growth factor receptor beta) is targeted by 85 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting PDGFRB
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | erlotinib | 5.55 | 256 |
| 2 | imatinib | 5.47 | 236 |
| 3 | lapatinib | 4.84 | 126 |
| 4 | foretinib | 4.34 | 76 |
| 5 | tozasertib | 4.33 | 75 |
| 6 | vandetanib | 4.30 | 73 |
| 7 | ponatinib | 4.26 | 70 |
| 8 | nilotinib | 4.17 | 64 |
| 9 | bosutinib | 4.08 | 58 |
| 10 | doramapimod | 4.06 | 57 |
| 11 | quizartinib | 3.99 | 53 |
| 12 | semaxanib | 3.93 | 50 |
| 13 | midostaurin | 3.85 | 46 |
| 14 | pazopanib | 3.69 | 39 |
| 15 | vatalanib | 3.69 | 39 |
| 16 | nintedanib | 3.61 | 36 |
| 17 | regorafenib | 3.56 | 34 |
| 18 | canertinib | 3.53 | 33 |
| 19 | tae 684 | 3.43 | 30 |
| 20 | pexidartinib | 3.43 | 30 |
| 21 | fedratinib | 3.40 | 29 |
| 22 | gilteritinib | 3.40 | 29 |
| 23 | linifanib | 3.33 | 27 |
| 24 | saracatinib | 3.33 | 27 |
| 25 | neflamapimod | 3.30 | 26 |
| 26 | sgi 1776 | 3.26 | 25 |
| 27 | tandutinib | 3.22 | 24 |
| 28 | Sorafenib | 3.14 | 22 |
| 29 | dovitinib | 3.09 | 21 |
| 30 | jnj 7706621 | 3.09 | 21 |
| 31 | lestaurtinib | 3.04 | 20 |
| 32 | pacritinib | 3.04 | 20 |
| 33 | lenvatinib | 3.04 | 20 |
| 34 | pf 03758309 | 3.00 | 19 |
| 35 | ruboxistaurin | 2.94 | 18 |
| 36 | ci 1040 | 2.94 | 18 |
| 37 | defosbarasertib | 2.89 | 17 |
| 38 | orantinib | 2.89 | 17 |
| 39 | barasertib | 2.89 | 17 |
| 40 | r 406 | 2.83 | 16 |
| 41 | k 252a | 2.83 | 16 |
| 42 | cediranib | 2.83 | 16 |
| 43 | su 9516 | 2.83 | 16 |
| 44 | milciclib | 2.77 | 15 |
| 45 | masitinib | 2.77 | 15 |
| 46 | pha 665752 | 2.71 | 14 |
| 47 | plx 4720 | 2.71 | 14 |
| 48 | crenolanib | 2.71 | 14 |
| 49 | kw 2449 | 2.64 | 13 |
| 50 | gsk 690693 | 2.64 | 13 |
Showing top 50 of 85 compounds. Use the BiohacksAI search to explore all PDGFRB modulators.
About PDGFRB as a Drug Target
PDGFRB (platelet derived growth factor receptor beta) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 85 compounds with documented PDGFRB interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
PDGFRB inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.